Herbalife Nutrition Launches Healthy Lifestyle Tips on Facebook

Food and Healthcare Press Releases Wednesday October 10, 2018 13:27
Bangkok--10 Oct--Francom Asia

Herbalife Nutrition, a premier global nutrition company, is launching a social media campaign to promote a healthier and happier life. Health enthusiasts can benefit from 30 innovative nutrition ideas, tips, recipes, games and more, for overall well-being. Follow "HerbalifeThailandOfficial" on Facebook for new posts that are easy to apply to your daily routine until end October, or search for previous ones to discover how a healthy active lifestyle and good nutrition can positively impact your life!

For more information on Herbalife Nutrition in Thailand, please visit www.Herbalife.co.th or call 02-660-1600.

Latest Press Release

Open nursing course to accelerate the safe practice of Peripheral Intravenous Cannula Insertion

"Peripheral Intravenous Cannula Insertion is a very broad term and not likely to be understood by people outside the medical community. In simple terms, it means the provision of saline, medication or blood products through an intravenous device and...

Sirtex Medical reaches milestone 100,000th patient dose delivery of SIR-Spheres(R) Y-90 resin microspheres

- Physicians and employees recognized for their role in this milestone and impact made on patient lives Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced delivery of the 100,000th patient dose of SIR-Spheres(R)...

Most Thai consumers want to improve their diets and are open to healthier product reformulation

According to a new report by Food Industry Asia (FIA) and research firm IGD, almost all consumers in Thailand (99 per cent) are interested in improving their diets and a majority (82 per cent) are happy for products to be reformulated, provided that...

Kemin Launches New Vision and Logo for the Future

Global ingredient manufacturer sets sights on sustainably transforming 80 percent of the world by 2042 Today Kemin Industries, a global ingredient manufacturer, unveiled its new global vision and logo to align the company strategically for 2042 and...

Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial

Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The...

Related Topics